DASH vs DNTH · P/E 76, rev $13.72B vs rev $6.2M
DoorDash, Inc. Class A Common Stock (DASH) versus Dianthus Therapeutics Inc. (DNTH) — a side-by-side from cached financials, not a winner call.
DoorDash, Inc. Class A Common Stock (DASH) is a internet retail company listed on US.
Dianthus Therapeutics Inc. (DNTH) is a biotechnology company listed on US.
Latest reported DASH revenue for 2025-12-31 was $13.72B. Net income was $935.0M. Revenue was up 27.9% from 2024-12-31 to 2025-12-31. DASH currently screens at market cap $69.41B and trailing P/E 75.9.
Latest reported DNTH revenue for 2024-12-31 was $6.2M. Net income was -$85.0M. Revenue was up 120.6% from 2023-12-31 to 2024-12-31. DNTH currently screens at market cap $4.40B.
DASH currently screens at market cap $69.41B and trailing P/E 75.9. DNTH currently screens at market cap $4.40B.
Not investment advice. Open the DASH and DNTH stock pages for the full models.
Not investment advice.